DMAA
Drugs Made In America Acquisition Corp. Rights
NASDAQ: DMAAR · ·
$0.13
-10.62% today
Updated 2026-06-05
Market cap
$1.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$—
Dividend yield
—
52W range
$0 – $0
Volume
0.1M
Drugs Made In America Acquisition Corp. Rights (DMAAR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-1.46%
Debt/equity
—